Author

Rimplejeet Kaur

Observed name: Kaur, Rimplejeet

Institutions: All India Institute of Medical Sciences Jodhpur, All India Institute of Medical Sciences, Rajkot, National Defence University of Malaysia

Observed institutions: Indian Institute of Technology Jodhpur, All India Institute of Medical Sciences Jodhpur, All India Institute of Medical Sciences, Rajkot, National Defence University of Malaysia

OpenAlex ID: A5037092249

Sample Size Calculation in Medical Research: A Primer

2021 · Jaykaran Charan, Rimplejeet Kaur, et al. · Annals of the National Academy of Medical Sciences (India) · 79

Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 Vaccines

2022 · Siddhartha Dutta, Rimplejeet Kaur, et al. · Cureus · 36

Hydroxychloroquine as Therapeutic Option in COVID-19: Analysis of Suspected Cardiovascular Adverse Drug Events Reported in the VigiBase

2021 · Siddhartha Dutta, Rimplejeet Kaur, et al. · Bangladesh Journal of Medical Science · 11

Letter to the editor - serious asthma events with fluticasone plus salmeterol versus fluticasone alone

2020 · Surjit Singh, Rimplejeet Kaur · Journal of Respiratory Diseases and Medicine

Works count: 5

Citation count: 126

H-index: 3

I10-index: 3